These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 9207175

  • 1. Association of coatomer proteins with the beta-receptor for platelet-derived growth factor.
    Hansen K, Rönnstrand L, Rorsman C, Hellman U, Heldin CH.
    Biochem Biophys Res Commun; 1997 Jun 27; 235(3):455-60. PubMed ID: 9207175
    [Abstract] [Full Text] [Related]

  • 2. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
    Yokote K, Hellman U, Ekman S, Saito Y, Rönnstrand L, Saito Y, Heldin CH, Mori S.
    Oncogene; 1998 Mar 12; 16(10):1229-39. PubMed ID: 9546424
    [Abstract] [Full Text] [Related]

  • 3. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G, Davis B, Kristensen SM, Sankar A, Linacre J, Stein RC, Panayotou G, Waterfield MD, Driscoll PC.
    J Mol Biol; 1998 Feb 20; 276(2):461-78. PubMed ID: 9512716
    [Abstract] [Full Text] [Related]

  • 4. Differential interaction of CrkII adaptor protein with platelet-derived growth factor alpha- and beta-receptors is determined by its internal tyrosine phosphorylation.
    Matsumoto T, Yokote K, Take A, Takemoto M, Asaumi S, Hashimoto Y, Matsuda M, Saito Y, Mori S.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):28-33. PubMed ID: 10733900
    [Abstract] [Full Text] [Related]

  • 5. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
    Sachsenmaier C, Sadowski HB, Cooper JA.
    Oncogene; 1999 Jun 17; 18(24):3583-92. PubMed ID: 10380880
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling.
    Yamamoto M, Toya Y, Jensen RA, Ishikawa Y.
    Exp Cell Res; 1999 Mar 15; 247(2):380-8. PubMed ID: 10066366
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.
    Jousset C, Carron C, Boureux A, Quang CT, Oury C, Dusanter-Fourt I, Charon M, Levin J, Bernard O, Ghysdael J.
    EMBO J; 1997 Jan 02; 16(1):69-82. PubMed ID: 9009269
    [Abstract] [Full Text] [Related]

  • 17. The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.
    Wollberg P, Lennartsson J, Gottfridsson E, Yoshimura A, Rönnstrand L.
    Biochem J; 2003 Mar 15; 370(Pt 3):1033-8. PubMed ID: 12444928
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation.
    Irusta PM, DiMaio D.
    EMBO J; 1998 Dec 01; 17(23):6912-23. PubMed ID: 9843497
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.